文献速递先天性心脏病外科

双心室与单心室异位综合征患者的结局:单中心五十年经验

Outcomes of Biventricular and Single Ventricle Heterotaxy Patients: A Single Center Five-Decade Experience.
PubMed 文献 · Ann Thorac Surg · 2022-06-17

该单中心回顾性研究分析了1973至2021年间230例异位综合征患者,比较单心室与双心室生理患者的长期生存。单心室生理患者30年生存率低于双心室患者(53%±4% vs 93%±5%,P=.001),无脾患者低于多脾患者(49%±5% vs 68%±5%,P<.001)。多脾伴双心室生理患者生存最佳(100%存活)。

要点

  • 单心室生理患者30年生存率显著低于双心室患者(53%±4% vs 93%±5%,P=.001)。
  • 无脾患者30年生存率显著低于多脾患者(49%±5% vs 68%±5%,P<.001)。
  • 多脾伴双心室生理患者30年生存率100%,为最佳亚组。

核心结论

  • 无脾患者生存率低于多脾患者,单心室生理患者生存率低于双心室生理患者。
  • 双心室生理合并多脾患者生存最佳。

研究设计与样本

  • 单中心回顾性研究,查询机构数据库纳入1973年至2021年异位综合征患者230例。
  • 比较单心室生理与双心室生理患者,其中单心室199例,双心室31例(20例手术干预,11例未手术)。

主要发现

  • 多脾占47%,无脾占53%;单心室生理199例,其中180例(78%)行Fontan姑息术。
  • Fontan中位年龄7.5岁(四分位距8.8),中位随访20年(四分位距21)。
  • 30年生存率:单心室53%±4% vs 双心室93%±5%(P=.001);无脾49%±5% vs 多脾68%±5%(P<.001)。
  • 多脾伴双心室生理30年生存率100%,无脾伴双心室生理为53%±25%(P<.001)。
  • 8例(3.5%)行心脏移植,中位年龄17岁。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical palliation of patients with heterotaxy syndrome has proven challenging. Long-term outcomes have historically been poor. Factors contributing to these outcomes are not completely understood. METHODS: The institutional databases were queried for patients with heterotaxy syndrome from 1973 to 2021. Comparisons were made between patients managed with single ventricle physiology and biventricular physiology. RESULTS: Heterotaxy syndrome was identified in 230 patients (polysplenia, 47%; asplenia, 53%). In all, 199 patients had single ventricle physiology; 180 (78%) had undergone Fontan palliation. Thirty-one patients had biventricular physiology, including 20 (9%) with surgical intervention and 11 (5%) without surgical intervention. Median age at Fontan was 7.5 years (interquartile range, 8.8). Median follow-up was 20 years (interquartile range, 21). Kaplan-Meier analysis showed decreased survival with single ventricle physiology (53% ± 4%, vs biventricular 93% ± 5% at 30 years; P = .001), as well as asplenia compared with polysplenia (49% ± 5% vs 68% ± 5% at 30 years; P < .001). Polysplenia patients with biventricular physiology demonstrated the best survival (100% alive, vs 53% ± 25% of asplenia biventricular at 30 years; P < .001). Overall, 8 patients (3.5%) underwent cardiac transplantation at a median age of 17 years. On multivariable analysis, risk factors associated with mortality included single ventricle physiology (odds ratio [OR] 7.2; 95% CI, 2.4-21.7), no prior Glenn (OR 3.6; 95% CI, 1.9-6.7), need for permanent pacemaker (OR 2.3; 95% CI, 1.2-4.6), and asplenia (OR 2.7; 95% CI, 1.5-5.0). CONCLUSIONS: Overall, patients with asplenia demonstrated decreased survival compared with patients with polysplenia; and single ventricle physiology had decreased survival compared with biventricular. Patients with biventricular physiology and polysplenia had the best survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Graham G, Dearani JA, Niaz T, et al. Outcomes of Biventricular and Single Ventricle Heterotaxy Patients: A Single Center Five-Decade Experience. Ann Thorac Surg. 2022. PMID: 35718202. doi:10.1016/j.athoracsur.2022.05.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。